Skip to main content

HANYS Benefit Services Partners with CyberScout on Identity Theft Protection Services

HBS expands employee benefits offerings to protect employees from the consequences of identity theft

HANYS Benefit Services is pleased to announce our partnership with CyberScout, a leading identity management and data theft services company. CyberScout delivers valuable prevention education, proactive protection services, and swift and appropriate incident remediation for more than 17.5 million households and more than 770,000 businesses.

The hidden cost of identity theft to employees and employers:

When identity thieves take advantage of employees’ stolen personal information to obtain credit or loans, or to commit various types of fraud, both employees and employers pay a steep price. For example, victims:
  • need 165 hours, on average, to resolve identity theft; 
  • are absent five times more than average; and
  • use twice as much sick time.
Consider that in 2017 the Equifax data breach alone exposed the sensitive personal information of 143 million people. And since there have been more than 1,792 breach incidents (that we know about), millions of people are at risk for fraud and identity theft.

As the exclusive CyberScout vendor for HANYS members, HBS has secured institutional pricing for these important programs.

"Today’s heightened cyber-risk environment is impacting us all and leading to the increased demand for our services," said Matt Cullina, CEO, CyberScout. "We're proud to partner with HANYS to deliver the highest caliber of identity management and credit monitoring solutions to protect its employees and customers from the pervasive problem of identity theft and fraud."

Employees and their families can rely on CyberScout’s fraud specialists to reduce their risks of identity theft. Further, should a breach or theft occur, they will receive unlimited resolution support and services including access to the CyberScout Resolution Center. Also offered is access to the CyberScout online Knowledge Center, which provides information and FAQs to help individuals minimize their exposure to cyber risk, along with other educational and cost-effective technology solutions. Other features include: placement of fraud alerts, assistance with filing police reports and fraud victim affidavits, credit grantor notifications, government agency and association notifications, creation of a comprehensive case file, and active post fraud follow-up, when an incident occurs.

CyberScout provides additional coverage by monitoring a full range of credit and non-credit information used to commit fraud. It searches public and private databases, social media channels, and the internet’s black market to detect possible misuse of customer identities and credit data. When a potential fraudulent activity is detected, customers receive an alert and are provided with full access to CyberScout’s 24/7 Resolution Center Support Team.

An affiliate of the Healthcare Association of New York State (HANYS), HBS shares HANYS' commitment to educating organizations on cybersecurity threats and providing tools and insights that help protect against data breaches.

For additional information about CyberScout's identify theft services and HBS' employee benefits solutions, contact Wesley Price at (518) 431-7758 or at wprice@hanys.org.
Labels:

Popular posts from this blog

SECURE 2.0 Discussion Series: Session Two

The retirement industry has been buzzing since the SECURE 2.0 Act was signed into law last December. This new, comprehensive legislation has sparked a lot of discussion. As with any major reform, it will take time for the industry to fully adapt and understand all its implications. Following our April 11 webinar on the first three months of the industry’s response, our team reconvened to discuss some of what we have heard from our client and vendor partners and to respond to some of the great questions we heard from attendees. Panel participants included the following HBS team members: Noah Buck, Christina Bauer-Dobias, Sean Bayne, Vincent Bocchinfuso and Kathleen Coonan. The Discussion SB – Throughout the webinar, I wanted to stress two things: 1) confusion about where to start and what is expected from plan sponsors is normal; and 2) even more than three months in, this is a developing situation and people should expect changes as time goes on. With those in mind, engagement through
Read more

SECURE 2.0 Discussion Series: Session One

SECURE 2.0 provisions: What we know and what’s still up in the air The SECURE 2.0 Act, signed into law in late December 2022, has factored heavily in retirement industry discourse since the final legislation was published. As with any legislation of this depth and breadth, there’s a lot to digest and the industry takes time to adjust. Our team of experienced advisors recently met to discuss some of the more nuanced provisions of the legislation, such as changes to Roth contributions, and what they could mean for plan sponsors. Panel participants included the following HBS team members: Noah Buck, Christina Bauer-Dobias, Sean Bayne, Vincent Bocchinfuso and Kathleen Coonan. Highlights of our panel’s conversation below should serve to help guide plan sponsor thinking. On Roth employer contributions NB – In addition to deferring pre-tax or Roth, plan sponsors can now allow employer contributions to be classified as Roth, is that right? VB – Correct. This is immediately available to plan s
Read more

What you should know about biosimilars

Rapidly increasing healthcare costs will likely continue to impact employers for the foreseeable future. As a result, many employers are considering strategies to manage these costs, including rising prescription drug costs. The introduction of biosimilar drugs as an alternative to biologics may bring value to healthcare by offering cost savings and increasing employee access to necessary medications. While biosimilars can potentially combat rising prescription drug costs, employers will need to learn more about them before considering how their health plans can accommodate these newer drugs. This article explores biosimilar drugs and ways employers can promote or manage their use. What are biosimilars? The European Medicines Agency defines a biosimilar as “a biological medicine highly similar to another already approved biological medicine.” It is produced from living organisms — humans, animals or microorganisms, meaning they aren’t created from synthesized chemicals. They are also
Read more